Skip to main
TEM
TEM logo

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 45%
Buy 18%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI Inc. has demonstrated strong financial performance, with total revenue growth of 35.9% year-over-year, driven by significant expansions in both Genomics and Data & Other segments. The company reported 72.5k NGS tests in 3Q24, reflecting a solid increase from both the previous quarter and the same period last year, indicating rising demand for its services. Furthermore, the positive outlook for revenue growth, projected to sustain a mid-30% pace, alongside a substantial improvement in EBITDA burn, underscores the firm's robust operational momentum and market positioning.

Bears say

The analysis highlights a negative outlook for Tempus AI based on key financial metrics and market conditions. A potential decline in reimbursement rates could hinder the company's growth trajectory, while any loss of market share in genomic testing or health system customers may adversely affect revenue generation from their dataset. Additionally, with an EV/revenue multiple of 8.3x for FY25, which is lower than its peers, and stagnant operating cash flow alongside significant debt levels, Tempus AI faces considerable financial pressures amid a competitive landscape.

TEM has been analyzed by 11 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 18% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 11 analysts, TEM has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $65.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $65.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.